Study of LATITUDE heart device monitoring
Part of Heart & circulation clinical trials.
This trial looks at how well the LATITUDE monitoring system works for people with heart devices. It checks if remote monitoring helps doctors track how your device is doing, so they can spot problems early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are willing to sign a consent form for using your health information.
- You are either about to get a heart device that uses the LATITUDE monitor, or you already have one.
- You can be followed at the same clinic for at least one year after getting the device.
- The device you are getting is approved for regular use (not experimental).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special monitoring system in your heart device (called HeartLogic) can help detect early warning signs of heart failure getting worse. It uses wireless check-ins to track your condition at home and alert your doctor if you need help.
This trial tests if using HeartLogic, a feature in your heart device that tracks early warning signs, can help your care team manage your heart failure better and keep you out of the hospital. If you already have a compatible CRT-D or ICD and use remote monitoring, you may be able to join.
This study tests a small chest sensor that tracks your heart activity while you're in the hospital. It may help doctors better manage heart failure and prevent future crises.
This study tests a heart failure alert system called HeartInsight in people who recently received an ICD or CRT-D device. The goal is to see if the alerts help doctors manage care better. You may qualify if you got a new (not replacement) device less than a year ago.
This study uses a special wearable device to record your heart's electrical signals. It is for people who have a pacemaker or CRT-P with a specific type of lead (LBBAP) and wants to check how well the therapy is working.
This study tests whether a small sensor (CardioMEMS) implanted in the lung artery can help doctors better manage LVAD settings and reduce hospital visits. It is for people who already have a HeartMate 3 heart pump and are stable enough to go home.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.